{"id":755,"date":"2017-02-14T08:50:51","date_gmt":"2017-02-14T07:50:51","guid":{"rendered":"http:\/\/intervacc.se\/en\/?page_id=755"},"modified":"2023-05-09T16:19:49","modified_gmt":"2023-05-09T14:19:49","slug":"pipeline","status":"publish","type":"page","link":"https:\/\/intervacc.se\/en\/research\/pipeline\/","title":{"rendered":"Pipeline"},"content":{"rendered":"<div class=\"preamble\">\n<p>Intervacc&#8217;s developmental program for new vaccines against animal infectious diseases is summarised in the following table.\u00a0Please, click on respective project name or indication to read more.<\/p>\n<\/div>\n\n<table id=\"tablepress-10\" class=\"tablepress tablepress-id-10\">\n<thead>\n<tr class=\"row-1 odd\">\n\t<th class=\"column-1\">Project<\/th><th class=\"column-2\">Disease area<\/th><th class=\"column-3\">Species<\/th><th class=\"column-4\">Preclinical<\/th><th class=\"column-5\">Clinical <\/th><th class=\"column-6\">Regulatory<\/th><th class=\"column-7\">Market<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-hover\">\n<tr class=\"row-2 even\">\n\t<td class=\"column-1\"><A href=\"\/en\/research\/pipeline\/strangvac\/\">Strangvac<sup>\u00ae<\/sup><\/a><\/td><td class=\"column-2\"><a href=\"\/en\/research\/pipeline\/strangvac\/strangles-in-horses\/\">Strangles<\/a><\/td><td class=\"column-3\">Horse<\/td><td class=\"column-4\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 100%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"border-radius: 0px 0 0 0px; width: 115%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td><td class=\"column-5\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 115%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"width: 115%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td><td class=\"column-6\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 115%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"border-radius: 0 5px 5px 0 ;width: 100%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td><td class=\"column-7\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 115%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"border-radius: 0 5px 5px 0 ;width: 20%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td>\n<\/tr>\n<tr class=\"row-3 odd\">\n\t<td class=\"column-1\"><a href=\"\/en\/research\/pipeline\/inv-274\/\">INV274<\/a><\/td><td class=\"column-2\"><a href=\"\/en\/research\/pipeline\/inv-274\/about-strep-suis\/\">Strep. suis infection<\/a><\/td><td class=\"column-3\">Piglets<\/td><td class=\"column-4\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 70%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"border-radius: 0 5px 5px 0 ;width: 100%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td><td class=\"column-5\"><\/td><td class=\"column-6\"><\/td><td class=\"column-7\"><\/td>\n<\/tr>\n<tr class=\"row-4 even\">\n\t<td class=\"column-1\"><a href=\"\/en\/research\/pipeline\/novel-antigen\/\">INV412<\/a><\/td><td class=\"column-2\"><a href=\"\/en\/research\/pipeline\/novel-antigen\/about-s-aureus-mastitis\/\">Staph. aureus mastitis<\/a><\/td><td class=\"column-3\">Cow<\/td><td class=\"column-4\"><div class=\"inwrap\" style=\"left: -8px; top: 4px; height: 22px; width: 25%; position: relative;\"><div><div class=\"stapel\" data=\"1\" style=\"border-radius: 0 5px 5px 0 ;width: 100%; height: 14px; background-color: #86C0D2!important ;\"><\/div><\/div><\/div><\/td><td class=\"column-5\"><\/td><td class=\"column-6\"><\/td><td class=\"column-7\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-10 from cache -->\n<p>The positive results of vaccination against strangles (Strangvac<sup>\u00ae<\/sup>), based on fusions of recombinant proteins, demonstrates that our technology can be applied also for development of other vaccines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intervacc&#8217;s developmental program for new vaccines against animal infectious diseases is summarised in the following table.\u00a0Please, click on respective project name or indication to read more. The positive results of vaccination against strangles (Strangvac\u00ae), based on fusions of recombinant proteins, demonstrates that our technology can be applied also for development of other vaccines.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":754,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"page-full-width.php","meta":{"inline_featured_image":false},"_links":{"self":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/755"}],"collection":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/comments?post=755"}],"version-history":[{"count":13,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/755\/revisions"}],"predecessor-version":[{"id":545252,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/755\/revisions\/545252"}],"up":[{"embeddable":true,"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/pages\/754"}],"wp:attachment":[{"href":"https:\/\/intervacc.se\/en\/wp-json\/wp\/v2\/media?parent=755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}